FDA Inspection 1306964 — Quagen Pharmaceuticals LLC

Quagen Pharmaceuticals LLC — FEI 3012403297

The FDA completed an inspection of Quagen Pharmaceuticals LLC on Apr 17, 2026 in West Caldwell, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Apr 17, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
West Caldwell, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.